哈特-漢克斯 HHS 深滬

已收盤 09-26 16:00:00 美东时间

3.70

+0.040

+1.09%

華盛通

立即下載

最高3.70
今開3.70
成交量 297股
最低 3.70
昨收 3.66
總市值 2743.48万
52周最高 7.4673
市盈率 ^靜 --
換手率 0.00%
52周最低 3.0627
委比 4.61%
總股本 741.48万
歷史最高 95.25
量比 0.03
振幅 0.00%
歷史最低 1.10
每手 1
風險率 1.18%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Trump’s 100% drug tariffs send pharma stocks lower

European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, including a 100% levy on branded and patented drugs starting October 1, with exemptions...

09-26 16:59
RFK Jr. reportedly weighs listing autism for vaccine compensation

Health and Human Services Secretary Robert F. Kennedy Jr. is considering plans to add certain autism symptoms to a list of adverse events that require his department to compensate under the national v...

09-26 03:28
RFK Jr. orders FDA investigation into safety of abortion pill mifepristone

HHS Secretary Robert F. Kennedy Jr has tasked the U.S. FDA with investigating the safety and efficacy of mifepristone, a drug used in medication abortions. The probe comes in response to requests from...

09-25 22:57
Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing the 340B drug discount program.

09-25 01:52
9月23日外盘头条：H-1B新规加剧美印关系恶化英伟达计划向OpenAI投资1000亿美元米兰首场政策秀称利率太高

全球财经媒体昨夜今晨共同关注的头条新闻主要有：　　1、特朗普H-1B新规加剧美印关系恶化贸易谈判蒙上阴影　　2、特朗普政府提出自...

09-23 05:57
特朗普政府提出自闭症与孕期使用泰诺成分之间未经证实的关联

特　　特朗普政府于周一提出，自闭症与孕妇使用对乙酰氨基酚之间存在未经证实的关联。对乙酰氨基酚是全球最常见的非处方止痛药之一 —— 健赞公司（Kenv...

09-23 05:34
Trump administration formally links Tylenol use in pregnancy to autism

Following a media report earlier this month that HHS was set to tie use of the painkiller Tylenol (acetaminophen) during pregnancy to developing autism, HHS Secretary Robert F. Kennedy Jr. has done ex...

09-23 05:17
据称特朗普政府计划将自闭症与孕期服用泰诺关联

　　据《华盛顿邮报》报道，特朗普政府计划于周一宣布，孕妇服用泰诺（Tylenol）可能与自闭症存在关联。　　《华盛顿邮报》周日援引四位知情人士的消息称，联邦卫...

09-22 05:55
Regeneron Donates Up To 500 Doses Of Ebola Drug Inmazeb To WHO For Countries Most At Risk

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will donate up to 500 doses of Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn), an Ebola treatment for the infection caused by

09-19 19:04
Five new members added to CDC vaccine advisory panel

The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have added five new members to the CDC Advisory Committee on Immunization Practices (ACI...

09-16 20:00

派息除權日	每股總股息	派息日期
2016-02-26	0.09	2016-03-15
2015-11-27	0.09	2015-12-15
2015-08-28	0.09	2015-09-15
2015-05-28	0.09	2015-06-15
2015-02-26	0.09	2015-03-16
2014-11-26	0.09	2014-12-15
2014-08-28	0.09	2014-09-15
2014-05-29	0.09	2014-06-13
2014-02-27	0.09	2014-03-14
2013-11-26	0.09	2013-12-16
2013-08-28	0.09	2013-09-16
2013-05-30	0.09	2013-06-14
2012-12-13	0.09	2012-12-28
2012-11-28	0.09	2012-12-14
2012-08-29	0.09	2012-09-14
2012-05-31	0.09	2012-06-15
2012-02-29	0.09	2012-03-15
2011-11-30	0.08	2011-12-13
2011-09-09	0.08	2011-09-27
2011-05-18	0.08	2011-06-03
2011-02-23	0.08	2011-03-11
2010-12-01	0.08	2010-12-14
2010-09-03	0.08	2010-09-21
2010-05-26	0.08	2010-06-11
2010-02-24	0.08	2010-03-12
2009-12-02	0.08	2009-12-15
2009-09-03	0.08	2009-09-21
2009-05-27	0.08	2009-06-12
2009-02-25	0.08	2009-03-13
2008-12-03	0.08	2008-12-16
2008-09-04	0.08	2008-09-19
2008-05-28	0.08	2008-06-13
2008-02-27	0.08	2008-03-14
2007-11-29	0.07	2007-12-14
2007-09-04	0.07	2007-09-14
2007-05-30	0.07	2007-06-15
2007-02-27	0.07	2007-03-15
2006-12-01	0.06	2006-12-15
2006-09-01	0.06	2006-09-15
2006-05-30	0.06	2006-06-15
2006-02-27	0.06	2006-03-15
2005-12-01	0.05	2005-12-15
2005-09-01	0.05	2005-09-16
2005-05-27	0.05	2005-06-15
2005-02-25	0.05	2005-03-15
2004-12-02	0.04	2004-12-15
2004-09-01	0.04	2004-09-15
2004-05-27	0.04	2004-06-15
2004-02-26	0.04	2004-03-15
2003-12-04	0.03	2003-12-15
2003-09-04	0.03	2003-09-15
2003-05-28	0.03	2003-06-13
2003-02-26	0.03	2003-03-14
2002-11-26	0.03	2002-12-13
2002-08-28	0.03	2002-09-13
2002-06-06	0.03	2002-06-15
2002-02-27	0.04	2002-03-15
2001-11-28	0.03	2001-12-14
2001-08-29	0.03	2001-09-14
2001-05-30	0.03	2001-06-15
2001-02-27	0.03	2001-03-15
2000-11-29	0.03	2000-12-15
2000-08-30	0.03	2000-09-15
2000-05-30	0.03	2000-06-15
2000-02-28	0.03	2000-03-15
1999-11-29	0.02	1999-12-15
1999-08-30	0.02	1999-09-15
1999-05-27	0.02	1999-06-15
1999-02-25	0.02	1999-03-15
1998-11-27	0.01	1998-12-15
1998-08-28	0.01	1998-09-15
1998-05-28	0.01	1998-06-15
1998-02-26	0.03	1998-03-16
1997-11-26	0.02	1997-12-15
1997-08-28	0.02	1997-09-16
1997-05-29	0.02	1997-06-16
1997-02-27	0.02	1997-03-17
1996-11-27	0.02	1996-12-16
1996-08-29	0.02	1996-09-16
1996-05-30	0.02	1996-06-17
1996-02-28	0.02	1996-03-15
1995-11-29	0.03	1995-12-15
1995-08-30	0.03	1995-09-15
1995-05-25	0.03	1995-06-15
1995-02-09	0.03	1995-03-01

公司名稱	哈特-汉克斯
行業分類	广告营销
業務描述	Harte-Hanks, Inc. is a global customer experience company operating in three business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company's mission is to partner with clients to provide them with a robust customer-experience, or CX, strategy, data-driven analytics and actionable insights combined with seamless program execution to better understand, attract, and engage their customers. Its services include strategic planning, data strategy, performance analytics, creative development, and execution, technology enablement, marketing automation, B2B and B2C e-commerce, cross-channel customer care, and product, print, and mail fulfillment. The company was founded in 1923 and is headquartered in Chelmsford, MA.

哈特-漢克斯 HHS 深 滬

3.70

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

哈特-漢克斯 HHS 深滬